x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharma and BioTech Daily

Pharma and BioTech News

Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai

news tech news

All Episodes

1:21

Pharma and Biotech Daily: Your Essential Guide to the...

Pharma and BioTech Daily ·

2025/03/20

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has made a $1 billion investment in Oxford Biotherapeutics to gain access to their antibody-drug conjugate platform for cancer targets. Cargo has laid off 90% of its staff and is exploring potential business combinations. Trump is considering budget cuts to the CDC's HIV prevention program, which could impact HIV drugmakers like Gilead and Merck. The rise of G...

en-us

2:14

Pharma and Biotech Daily: Stay Ahead in Healthcare...

Pharma and BioTech Daily ·

2025/03/19

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Sarepta's DMD gene therapy patient dies, causing a 22% drop in shares.Sarepta experienced a significant setback as a patient participating in their DMD gene therapy trial tragically passed away, leading to a 22% decrease in their shares.## Arbor raises $73.5 million for gene editing research.Arbor successfully secured $73.5 million in funding to further their res...

en-us

1:56

Pharma and Biotech Daily: A Roundup of Key Industry...

Pharma and BioTech Daily ·

2025/03/18

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AstraZeneca has recently made a significant investment of up to $1 billion in cell therapy through the acquisition of esobiotec. This move is part of AstraZeneca's larger strategy to expand in the cell therapy space, positioning itself to be a major player in the market. Dyne is also looking to file for accelerated approval for its Duchenne exon skipping oligomer, w...

en-us

1:04

Pharma and Biotech Daily: GLP-1 Drug for Alcohol Use...

Pharma and BioTech Daily ·

2025/03/17

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Altimmune, a biopharmaceutical company based in Maryland, has announced plans to test an investigational drug based on GLP-1 for the treatment of alcohol use disorder. This drug is also being studied by Eli Lilly and Novo Nordisk for alcohol- and liver-related conditions. Altimmune joins these companies in exploring the potential of GLP-1 agonists for this indicati...

en-us

0:40

Pharma and Biotech Daily: Top News in the Industry

Pharma and BioTech Daily ·

2025/03/14

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Trump administration has withdrawn CDC nominee Dave Weldon at the last minute, while NIH and FDA picks advance. Acelyrin has implemented a poison pill strategy to prevent Tang Capital from acquiring the company. Johnson & Johnson and Legend Biotech are investing $150 million to increase Carvykti production. Mallinckrodt and Endo have announced a $6.7 billion...

en-us

1:19

Pharma and Biotech Daily: Navigating the...

Pharma and BioTech Daily ·

2025/03/13

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Bluebird bio has made the decision to go private in order to restructure and focus on long-term growth amidst declining valuations and funding challenges in the biotech industry. This move reflects a strategic shift in response to the current market conditions. Johnson & Johnson continues to face legal battles over talc products, with a pending ruling that could ...

en-us

0:49

Pharma and Biotech Daily: Breaking News and Insights...

Pharma and BioTech Daily ·

2025/03/12

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Bristol Myers Squibb (BMS) has acquired 2seventy, the partner of Abecma, for $286 million, ending their cost-sharing agreement. Abecma generated $406 million in 2024, with BMS paying $43 million to 2seventy as part of their profit-sharing agreement.Beam Therapeutics has achieved genetic correction in AATD, while Viking secured a 1 billion supply of an obesity pill c...

en-us

1:57

Pharma and Biotech Daily: Novo's Weight Loss Drug...

Pharma and BioTech Daily ·

2025/03/11

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo's next-generation weight loss drug, cagrisema, has disappointed once again with lower-than-expected weight loss results. The latest data showed only a 15.7% weight loss in patients with diabetes after 68 weeks, below the company's projections. This news has caused Novo's stock to dip. Additionally, side effects associated with GLP-1-based obesity drugs are turn...

en-us

1:06

Pulse on Pharma: Updates and Insights from the Industry

Pharma and BioTech Daily ·

2025/03/10

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. J&J has recently halted a late-stage depression trial due to lack of efficacy. Analysts do not believe this will have a significant impact on the company's broader neuroscience strategy. Meanwhile, there seems to be confusion at the FDA with terminations and reversals happening. In other news, Novo Nordisk has conducted limited studies on GLP-1s for addicti...

en-us

1:00

Pharma and Biotech Daily: Stay Informed on the Latest...

Pharma and BioTech Daily ·

2025/03/07

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Industry is anxiously awaiting the hearing for FDA commissioner nominee Marty Makary, following disruptions and layoffs at the FDA. Novo Nordisk and Eli Lilly are intervening in legal battles against drug compounders over shortages of glp-1 compounds. ARS Pharmaceuticals has received FDA approval for Neffy spray for children with anaphylaxis. A Pitchbook report foun...

en-us

1:27

Pharma and Biotech Daily: Novo Nordisk's Wegovy...

Pharma and BioTech Daily ·

2025/03/06

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Novo Nordisk has launched a direct-to-consumer program for their drug Wegovy, offering it at a reduced price of $499 per month for uninsured or underinsured patients, less than half of the drug's list price. Meanwhile, rare disease biotechs are facing challenges as Congress has failed to renew the rare pediatric disease priority review program, creating uncertainty...

en-us

0:39

Pharma and Biotech Daily: Reshoring, Setbacks, and...

Pharma and BioTech Daily ·

2025/03/05

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Pfizer and Eli Lilly are considering reshoring manufacturing in the U.S. in response to President Trump's tariff threats. Biohaven faces setbacks in clinical trials, while Roche gains FDA approval for a stroke drug expansion. Startup Delphia aims to use a precision medicine approach to target cancer cells. Industry leaders will discuss orphan drug development at the W...

en-us

1:28

Pharma and Biotech Daily: Your Essential Update on...

Pharma and BioTech Daily ·

2025/03/04

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. AbbVie has recently entered the obesity market through a deal with Gubra for Amylin, worth up to $2.2 billion. This move positions AbbVie among industry leaders like Novo Nordisk and Eli Lilly. The focus on redefining obesity as a chronic disease is gaining momentum, with recent FDA documents and The Lancet Diabetes & Endocrinology commission highlighting the i...

en-us

1:01

Pharma and Biotech Daily: Breaking News in the World...

Pharma and BioTech Daily ·

2025/03/03

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Lilly has entered a $1.6 billion deal in the molecular glue space, following the steps of other big pharma players like Novo Nordisk, Pfizer, and Novartis. On the other hand, the FDA, NIH, and CDC are experiencing chaos with canceled meetings and postponed discussions since Donald Trump's return as U.S. president, without a clear reason. In other news, Cassava's stock...

en-us

0:44

Pharma and Biotech Daily: The Weekly Roundup in the...

Pharma and BioTech Daily ·

2025/02/28

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. The FDA's vaccine planning meeting was canceled due to disruptions caused by Robert F. Kennedy Jr. GSK's CEO Emma Walmsley received a pay increase to align with industry standards. Lilly invested $27 billion in US manufacturing after Trump's tariff threats. Regeneron scaled back approval goals for a lymphoma bispecific drug. Kallyope released disappointing data...

en-us

1:32

Pharma and Biotech Daily: Navigating the...

Pharma and BioTech Daily ·

2025/02/27

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The Epic Act has been reintroduced in Congress to remove the IRA's 'pill penalty', with hopes for positive changes. However, budgetary constraints may make it challenging for the current administration to make significant amendments to the IRA. As money continues to flow into weight loss drugs, physicians are prioritizing efficacy and access. Emalex is moving towards ...

en-us

1:14

Pharma and Biotech Daily: Stay Informed on Industry...

Pharma and BioTech Daily ·

2025/02/26

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. J&J is currently involved in a legal battle with Samsung Bioepis, alleging unlawful sublicensing of a Stelara biosimilar. Meanwhile, Takeda has made a significant investment in a new BridGene partnership aimed at targeting undruggable targets. In other news, Regeneron has made strides in developing a gene therapy that can restore hearing in patients with rare g...

en-us

1:44

Breaking News in Pharma and Biotech: From Trump's...

Pharma and BioTech Daily ·

2025/02/25

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Trump has threatened big pharma with tariffs unless they reshore manufacturing. He also refused to promise pharma executives that he would hamstring the IRA's drug negotiation program. RNA editing is fueling hope for rare and common diseases, with experts calling for more efficiency and breakthroughs in delivery methods. The FDA is rehiring scientists afte...

en-us

3:09

Pharma and Biotech Daily: FDA Approves New Treatments...

Pharma and BioTech Daily ·

2025/02/24

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Title: Pfizer and BioNTech seek FDA approval for COVID-19 vaccine boosterPfizer and BioNTech have announced that they are seeking authorization from the FDA for a booster dose of their COVID-19 vaccine. The companies have presented data showing that a third dose of the vaccine can significantly increase protection against the Delta variant.##Title: Moderna to supp...

en-us

4:05

Pharma and Biotech Daily: Your Daily Dose of What...

Pharma and BioTech Daily ·

2025/02/21

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##COVID-19 vaccine distribution challenges##As the world races to distribute COVID-19 vaccines, challenges arise in ensuring equitable distribution. Limited supplies, logistical issues, and vaccine hesitancy all contribute to the complexity of the distribution process. Governments and organizations must work together to address these challenges and ensure that vacci...

en-us

478 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci